Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Frances Wang 2025 Dec 07, 16:00

BTCUSD price prediction: could Bitcoin price reach $100K in 2026?

Frances Wang 2025 Dec 07, 16:00

Gold price (XAU/USD) dips to $4,195: Are gold prices expected to rise 2026?

Ghko B 2025 Dec 07, 16:00

EV Stocks Yearly Recap: Rivian (RIVN) Stock, NASDAQ: TSLA, NIO Stock

Frances Wang 2025 Dec 07, 16:00

Gold (XAU/USD) Price today: Gold rebounds above $4,200, what’s next?

Ghko B 2025 Dec 07, 16:00

Quantum stocks analysis: IONQ stock dips 3%, will IONQ surge again?

Frances Wang 2025 Dec 07, 16:00

EV stocks analysis: NIO stock dips, TSLA trades near $430, LCID is falling

Frances Wang 2025 Dec 07, 16:00

Quantum Stocks to Watch: IONQ Stock, QBTS Stock, D-Wave Stock

Ghko B 2025 Dec 07, 16:00

Top Growth Stocks to Buy in 2026: TSLA, NVDA, AMZN stock, Apple (AAPL) stock

Ghko B 2025 Dec 07, 16:00

Best AI stocks to buy: AMD stock, Nebius (NBIS) stock, CoreWeave (CRWV)

Ghko B 2025 Dec 04, 16:00

Bitcoin price prediction: BTC/USD rebounds, is BTC expected to rise further?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

0.33

Spread (%)

0.6407 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

14:31 - 20:59

Monday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

106164527104

Shares Outstanding

2035753027

Earnings Date (Next)

2001-08-07

Div Yield

2025-11-03

Ex-Dividend Date

2025-10-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0476

EPS

2.97

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Dec 07, 16:00

Crypto CFD trading: What are crypto CFDs, how to trade crypto with CFDs?

Ghko B 2025 Dec 04, 16:00

How to trade gold: Trading tips on gold CFDs, Short-term trades in XAU/USD

Ghko B 2025 Dec 03, 16:00

What are the most traded indices: how to trade indices CFD with markets.com?

Trustpilot